Institutional Biosafety Committee (IBC)

The IBC is responsible for reviewing projects in which biohazards are used ensuring that research is conducted safely and that risks are assessed and minimized – see IBC Charge. The IBC reviews and approves projects and issues Biohazard Use Authorization (BUA) permits per the standard operating procedure: SOP IBC BUA Review and Approval Process. Visit the Biohazard Use Authorization (BUA) web page to register, renew, or amend a BUA.

biohazard use authorization >>

Additionally, Human Gene Transfer (HGT) clinical trials need to be reviewed by an IBC. Before HGT clinical trials can commence, the study teams need to fulfill a specific set of requirements before they can be approved by the IBC. Read more about the IBC approval process for HGT clinical trials.

HGT clinical trials >>

IBC Deadlines and Meeting Dates

Protocol Submission DeadlineIBC Meeting DatesMeeting Details
November 9, 2025November 20, 2025IBC Minutes 11/20/2025
December 7, 2025December 18, 2025Zoom >>
January 6, 2026January 22, 2026Zoom >>
February 10, 2026February 26, 2026Zoom >>
March 10, 2026March 26, 2026Zoom >>
April 7, 2026April 23, 2026Zoom >>
May 12, 2026May 28, 2026Zoom >>
June 9, 2026June 25, 2026Zoom >>
July 7, 2026July 23, 2026Zoom >>
August 11, 2026August 27, 2026Zoom >>
September 8, 2026September 24, 2026Zoom >>
October 6, 2026October 22, 2026Zoom >>
October 27, 2026November 12, 2026Zoom >>
November 24, 2026December 10, 2026Zoom >>